| 1 | Syndrome | 3.39% | |
| 2 | Associated | 3.39% | |
| 3 | Immune | 1.69% | |
| 4 | Meta-Analysis | 1.69% | |
| 5 | Clinical | 1.69% | |
| 6 | Spectrum | 1.69% | |
| 7 | Service | 1.69% | |
| 8 | Atezolizumab | 1.69% | |
| 9 | Huntington | 1.69% | |
| 10 | Paraneoplastic | 1.69% | |
| 11 | Hospital | 1.69% | |
| 12 | Therapy | 1.69% | |
| 13 | Systematic | 1.69% | |
| 14 | Severe | 1.69% | |
| 15 | Rituximab | 1.69% | |
| 16 | Refractory | 1.69% | |
| 17 | Standard | 1.69% | |
| 18 | Patients | 1.69% | |
| 19 | Infiltration | 1.69% | |
| 20 | Factory | 1.69% | |
| 21 | Lupus | 1.69% | |
| 22 | Westmead | 1.69% | |
| 23 | Pediatric | 1.69% | |
| 24 | Receptor | 1.69% | |
| 25 | Review | 1.69% | |
| 26 | Cholecystectomy | 1.69% | |
| 27 | Antibody-Positive | 1.69% | |
| 28 | Warning | 1.69% | |
| 29 | Miroma | 1.69% | |
| 30 | Parkinson’s | 1.69% | |
| 31 | Become | 1.69% | |
| 32 | Anti-CV2/CRMP5 | 1.69% | |
| 33 | Subcortical | 1.69% | |
| 34 | Systemic | 1.69% | |
| 35 | Erythematosus | 1.69% | |
| 36 | Endometriosis | 1.69% | |
| 37 | Thrombocytopenia | 1.69% | |
| 38 | Oncology | 1.69% | |
| 39 | Expanding | 1.69% | |
| 40 | Should | 1.69% | |
| 41 | Anti-Hu | 1.69% | |
| 42 | Liver | 1.69% | |
| 43 | Recurrence | 1.69% | |
| 44 | Capsular | 1.69% | |
| 45 | Thrombopoietin | 1.69% | |
| 46 | Project | 1.69% | |
| 47 | Pain | 1.69% | |
| 48 | Belimumab | 1.69% | |
| 49 | Type | 1.69% | |
| 50 | Aphasia | 1.69% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
IARC at European Liver Patients’ Association policy event at European Parliament
International Agency for Research on Cancer
2025-12-15 17:30:58
FFR-CT: AI tool predicts heart attack risk in angina patients - healthcare-in
europe.com
2025-12-15 16:02:19